Trademarks = 4

Forward Citations = 0

Loading Chart...

14 inventors (with patents filed for the assignee):

Paul Goldsmith (5 out of 5 patents)

Michael Catt (3 out of 3 patents)

David Cox (2 out of 22 patents)

4. Joe Coghlin (2 out of 2 patents)

5. Tom Godec (2 out of 2 patents)

6. David Bruce Campbell (2 out of 2 patents)

7. Andrew John McGlashan Richards (1 out of 11 patents)

8. Hakim Adam Yadi (1 out of 1 patent)

9. Felicity Kate Sartain (1 out of 1 patent)

10. David O'Regan (1 out of 1 patent)

11. Bruce Campbell (1 out of 1 patent)

12. Andrew John Mcglashan Richards (1 out of 1 patent)

13. David Collier (1 out of 1 patent)

14. Bruce Campbell (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12653811 - Dosage regimen of amlodipine (2026-06-16),

2. 12597496 - Dosing of incretin pathway drugs (2026-04-07),

3. 12420014 - Dosing of incretin pathway drugs (2025-09-23),

4. 12295943 - Apixaban dosing (2025-05-13),

5. 11710547 - Methods and systems for providing personalised medicine to a patient (2023-07-25),

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#156 in Cambridge

#3,210 in United Kingdom

Cambridge, United Kingdom

Closed Loop Medicine Ltd.

Forward Citations = 0

14 inventors:

Paul Goldsmith (5 out of 5 patents)

Michael Catt (3 out of 3 patents)

David Cox (2 out of 22 patents)

4. Joe Coghlin (2 out of 2 patents)

5. Tom Godec (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Closed Loop Medicine Ltd.. Retrieved from https://idiyas.com/company/closed-loop-medicine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]